Carrick Therapeutics and The Menarini Group Announce Collaboration on Clinical Trials to Evaluate Samuraciclib and Elacestrant Combination


Hitesh

The Menarini Group, a renowned international private equity pharmaceutical company private sector, and Carrick Therapeutics, an oncology-focused biopharmaceutical company that discovers and develops highly distinct therapies, today announced a clinical trial collaboration and supply agreement. This agreement covers the conduct of a Phase 2 clinical trial to assess Carrick’s novel […]

Kedrion Expands Its System Of Plasma Gathering Facilities


Hitesh

The acquisition of the Czech firms UNICAplasma sro and UNICAplasma Morava sro, which run five plasma collection centres in the Czech Republic, was announced by Kedrion, an Italian global biopharmaceutical company that collects and fractionates blood plasma to make and distribute plasma-derived drugs for the treatment of serious diseases and […]

Organ Recovery Systems’ LifePort® Liver Transporter Preserves First Livers for Transplant as Part of the PILOT™ Continued Access Study


Hitesh

Organ Recovery Systems (ORS) is commemorating the first liver transplants performed at Northwestern Memorial Hospital in Chicago, Illinois, and Rutgers Medical School in New Jersey using the LifePort Liver Transporter (LLT) and Vasosol®. LLT reduces organ deterioration during preservation using oxygenated hypothermic machine perfusion (HMP), which improves patient outcomes and […]

GE Board of Directors Approves Separation of GE HealthCare


Hitesh

General Electric Company announced today that its Board of Directors has approved the previously announced spin-off of its healthcare business, GE Healthcare Holding LLC (“GE HealthCare”). Prior to such spin-off, GE HealthCare is expected to be converted into a corporation and renamed GE HealthCare Technologies Inc. The company is expected […]